I understand this, and Dr. Hauser (Tampa location) said it to me in person two years ago...not verbatim, from memory only: There has been a lot of problems with infection at the abdominal wall site where the feed goes into the gut. I hope this has been resolved by now.
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
Last Updated: January 22, 2009
http://www.clinicaltrials.gov/ct/show/NCT00357994
Purpose
The primary objective of this study will be to demonstrate the superiority of levodopa - carbidopa intestinal gel over treatment with optimized oral levodopa/carbidopa during 12 weeks.The study duration is 4 months.
Study Type: Interventional
Study Design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title: A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study of Levodopa/Carbidopa Suspension for Upper-Intestinal Infusion in Levodopa-Responsive Parkinson's Subjects Receiving Optimized Treatments With Parkinson Medicinal Products Who Continue to Experience Persistent Motor Fluctuations
Locations
United States, FloridaSite 107 Not yet recruiting
Gainesville, Florida, United State
Site 106 Not yet recruiting
Tampa, Florida, United States
United States, PennsylvaniaSite 124 Not yet recruiting
Philadelphia, Pennsylvania, United States
Germany
Site 435 Recruiting
Marburg, Germany
Site 434 Not yet recruiting
Leipzig, Germany
Site 437 Not yet recruiting
Kiel, Germany
Site 438 Not yet recruiting
Hannover, Germany
Site 436 Recruiting
Bremerhaven, Germany
Site 433 Not yet recruiting
Dresden, Germany
Site 439 Not yet recruiting
Bochum, Germany